Curanex Pharmaceuticals (CURX) vs Cadrenal Therapeutics (CVKD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Cadrenal Therapeutics is the larger company by market cap ($7.0 million vs $6.9 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CURX | CVKD |
|---|---|---|
| Share price | $4.41 | $1.70 |
| Market cap | $6.92M | $7.01M |
| 1-day change | -0.67% | +0.59% |
| EPS (TTM) | $-8.78 | $-3.67 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Net income (latest FY) | $-4.23M | $-13.24M |
| 52-week high | $13.34 | $12.50 |
| 52-week low | $3.58 | $0.816 |
| Distance from 52-week high | -66.94% | -86.40% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +723.53% |
| Average volume | 17.83K | 496.14K |
| Shares outstanding | 1.57M | 4.12M |
| Employees | 6 | 5 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Curanex Pharmaceuticals
CURX stock →Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients with inflammatory diseases. It develops Phyto-N for various therapeutic areas, including ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, and gout.
Health Care · Biotechnology: Pharmaceutical Preparations · 6 employees
About Cadrenal Therapeutics
CVKD stock →Cadrenal Therapeutics, Inc. operates as a late-stage biopharmaceutical company that develops novel therapies for life-threatening immune and thrombotic conditions.
Health Care · Biotechnology: Pharmaceutical Preparations · 5 employees
CURX vs CVKD FAQ
Which is bigger, Curanex Pharmaceuticals or Cadrenal Therapeutics?
Cadrenal Therapeutics (CVKD) is larger, with a market capitalization of $7.01M compared with $6.92M for Curanex Pharmaceuticals (CURX).
Are Curanex Pharmaceuticals and Cadrenal Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.